Streetbeat News

Stock Prices

GANX

Gain Therapeutics is hosting a webinar to discuss data from its Phase 1 study of GT-02287 for Parkinson's Disease, which was recently presented at a major international congress.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:07 am

BYDDF

BYDDY

BYD Co. has reached a significant milestone by producing its 9 millionth new energy vehicle (NEV), a red Yangwang U9 supercar. This achievement highlights BYD's rapid growth in the NEV market, having produced its 8 millionth NEV just two months prior. The company has also surpassed Tesla in battery electric vehicle sales in the last quarter of 2023.

Portfolio Pulse from Anan Ashraf

September 26, 2024 | 11:06 am

KTTA

Pasithea Therapeutics reported positive safety, tolerability, and preliminary efficacy data from its Phase 1 trial of PAS-004. A patient with stage 3 colon cancer showed stable disease with no adverse events, supporting the drug's potential as a MEK inhibitor.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:05 am

LUV

Southwest Airlines is reducing its headcount through controlled hiring and attrition, achieving labor cost certainty.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:05 am

ACXP

Acurx Pharmaceuticals (NASDAQ:ACXP) announced promising data on ibezapolstat, showing its positive effects on the gut microbiome and potential in treating C. difficile infections. The drug demonstrated favorable pharmacokinetics and efficacy against B. anthracis, including resistant strains.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:04 am

LUV

Southwest Airlines has revised its Q3 RASM expectations to increase by 2% to 3%, up from a previous forecast of flat to down 2%. This improvement is attributed to customer reaccommodation from other airlines' cancellations and better industry demand trends.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:01 am

MU

QQQ

SPY

US stocks are set for a strong start with Micron's earnings boosting market momentum. China's economic stimulus and upcoming US economic data are influencing market sentiment. Micron's stock surged over 15% in premarket trading, while SPDR S&P 500 ETF and Invesco QQQ ETF also saw gains.

Portfolio Pulse from Shanthi Rexaline

September 26, 2024 | 10:59 am

BDX

Becton, Dickinson (BD) has announced new data showcasing the effectiveness of its BD HealthSight Diversion Management software in identifying controlled substance diversion in operating rooms. The software led to a 55% increase in charting discrepancies detection and improved efficiency in resolving incidents.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:57 am

KMX

CarMax reported Q2 earnings per share of $0.85, missing the $0.86 estimate, but sales of $7.01 billion beat the $6.79 billion estimate. EPS increased by 13.33% from last year, while sales decreased by 0.86% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:53 am

ACN

Accenture reported its Q4 2024 earnings, with adjusted EPS of $2.79 beating the estimate of $2.77, and sales of $16.406 billion surpassing the expected $16.386 billion.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:41 am